How does Samsung Biologics apply a quality-by-design (QbD) approach to technology transfer and process characterization for biologics?
In the latest Contract Pharma whitepaper, our MSAT Senior Director Nilesh Deshmukh discusses the role of tech transfer and process validation in a drug’s lifecycle, design of experiments in characterization, and a case study for the monoclonal antibody process.
How does Samsung Biologics apply a quality-by-design (QbD) approach to technology transfer and process characterization for biologics?
In the latest Contract Pharma whitepaper, our MSAT Senior Director Nilesh Deshmukh discusses the role of tech transfer and process validation in a drug’s lifecycle, design of experiments in characterization, and a case study for the monoclonal antibody process.
- CDO
- CGMP
- ADC
- Bio Campus
- IR
- CMO
Share article